Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Leobon S"" wg kryterium: Autor


Wyświetlanie 1-4 z 4
Tytuł:
Patient Identification and Tumor Identification Management: Quality Program in a Cancer Multicentric Clinical Data Warehouse.
Autorzy:
Pallier K; Centre de Coordination en Cancérologie de la Haute-Vienne - 3C87, CHU de Limoges, Limoges, France.
Prot O; Univ. Limoges, CNRS, XLIM, UMR 7252, Limoges, France.
Naldi S; Univ. Limoges, CNRS, XLIM, UMR 7252, Limoges, France.
Silva F; Univ. Limoges, CNRS, XLIM, UMR 7252, Limoges, France.
Denis T; Département Exploitation Réseaux et Infrastructures - DSI, CHU Limoges, Limoges, France.
Giry O; Département Exploitation Réseaux et Infrastructures - DSI, CHU Limoges, Limoges, France.
Leobon S; Department of oncology, CHU de Limoges, Limoges, France.
Deluche E; Department of oncology, CHU de Limoges, Limoges, France.
Tubiana-Mathieu N; Centre de Coordination en Cancérologie de la Haute-Vienne - 3C87, CHU de Limoges, Limoges, France.
Pokaż więcej
Źródło:
Cancer informatics [Cancer Inform] 2023 May 19; Vol. 22, pp. 11769351231172609. Date of Electronic Publication: 2023 May 19 (Print Publication: 2023).
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
Degradation of skeletal mass in locally advanced oesophageal cancer between initial diagnosis and recurrence.
Autorzy:
Zouhry Y; Medical Oncology Department, Limoges University Hospital, 2 avenue Martin Luther King, 87042, Limoges, France.
Taibi A; Digestive Surgery Department, Limoges University Hospital, 2 avenue Martin Luther King, 87042, Limoges, France.
Durand-Fontanier S; Digestive Surgery Department, Limoges University Hospital, 2 avenue Martin Luther King, 87042, Limoges, France.
Darbas T; Medical Oncology Department, Limoges University Hospital, 2 avenue Martin Luther King, 87042, Limoges, France.
Forestier G; Neuroradiology Department, Limoges University Hospital, 2 avenue Martin Luther King, 87042, Limoges, France.
Monteil J; Nuclear Medicine Department, Limoges University Hospital, 2 avenue Martin Luther King, 87042, Limoges, France.
Lebrun-Ly V; Medical Oncology Department, Limoges University Hospital, 2 avenue Martin Luther King, 87042, Limoges, France.
Fayemendy P; Nutrition Unit, Limoges University Hospital, 2 avenue Martin Luther King, 87042, Limoges, France.; Tropical Neuroepidemiology Institute GEIST, INSERM, U1094, 33 rue François Mitterrand, 87032, Limoges, France.
Leobon S; Medical Oncology Department, Limoges University Hospital, 2 avenue Martin Luther King, 87042, Limoges, France.
Jesus P; Medical Oncology Department, Limoges University Hospital, 2 avenue Martin Luther King, 87042, Limoges, France.
Deluche E; Medical Oncology Department, Limoges University Hospital, 2 avenue Martin Luther King, 87042, Limoges, France. .
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2021 Dec 07; Vol. 21 (1), pp. 1313. Date of Electronic Publication: 2021 Dec 07.
Typ publikacji:
Journal Article
MeSH Terms:
Esophageal Neoplasms/*physiopathology
Neoplasm Recurrence, Local/*physiopathology
Sarcopenia/*mortality
Adult ; Aged ; Aged, 80 and over ; Body Composition ; Body Mass Index ; Esophageal Neoplasms/complications ; Esophageal Neoplasms/mortality ; Female ; Follow-Up Studies ; Humans ; Incidence ; Male ; Middle Aged ; Muscle, Skeletal/physiopathology ; Neoplasm Recurrence, Local/complications ; Neoplasm Recurrence, Local/mortality ; Prognosis ; Proportional Hazards Models ; Prospective Studies ; Retrospective Studies ; Sarcopenia/diagnostic imaging ; Sarcopenia/etiology ; Survival Rate ; Tomography, X-Ray Computed
Czasopismo naukowe
Tytuł:
Can the Six-Minute Walk Test Be Used to Individualize Physical Activity Intensity in Patients with Breast Cancer?
Autorzy:
Tubiana-Mathieu N; Department of Medical Oncology, CHU de Limoges, 87000 Limoges, France.; CAPTuR, EA3842, Faculty of Medicine, University Hospital, 87000 Limoges, France.
Cornette T; Department of Medical Oncology, CHU de Limoges, 87000 Limoges, France.; Department of Physiology, University Hospital, 87000 Limoges, France.
Mandigout S; HAVAE, EA6310, Faculty of Science and Technology, University of Limoges, 87000 Limoges, France.
Leobon S; Department of Medical Oncology, CHU de Limoges, 87000 Limoges, France.
Vincent F; Department of Physiology, University Hospital, 87000 Limoges, France.
Venat L; Department of Medical Oncology, CHU de Limoges, 87000 Limoges, France.
Deluche E; Department of Medical Oncology, CHU de Limoges, 87000 Limoges, France.; CAPTuR, EA3842, Faculty of Medicine, University Hospital, 87000 Limoges, France.
Pokaż więcej
Źródło:
Cancers [Cancers (Basel)] 2021 Nov 22; Vol. 13 (22). Date of Electronic Publication: 2021 Nov 22.
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
Assessment of Ki67 and uPA/PAI-1 expression in intermediate-risk early stage breast cancers.
Autorzy:
Deluche E; Department of Medical Oncology, University Hospital, 2 avenue Martin Luther King, F-87042, Limoges, France. .
Venat-Bouvet L; Department of Medical Oncology, University Hospital, 2 avenue Martin Luther King, F-87042, Limoges, France.
Leobon S; Department of Medical Oncology, University Hospital, 2 avenue Martin Luther King, F-87042, Limoges, France.
Fermeaux V; Department of Pathology, University Hospital, F-87042, Limoges, France.
Mollard J; Department of Gynaecology, Mother and Child Hospital, F-87042, Limoges, France.
Saidi N; Department of Radiotherapy, University Hospital, F-87042, Limoges, France.
Jammet I; Department of Senology, Mother and Child Hospital, F-87042, Limoges, France.
Aubard Y; Department of Gynaecology, Mother and Child Hospital, F-87042, Limoges, France.
Tubiana-Mathieu N; Department of Medical Oncology, University Hospital, 2 avenue Martin Luther King, F-87042, Limoges, France.
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2017 Sep 27; Vol. 17 (1), pp. 662. Date of Electronic Publication: 2017 Sep 27.
Typ publikacji:
Journal Article
MeSH Terms:
Breast Neoplasms/*drug therapy
Ki-67 Antigen/*genetics
Neoplasm Recurrence, Local/*drug therapy
Plasminogen Activator Inhibitor 1/*genetics
Urokinase-Type Plasminogen Activator/*genetics
Adult ; Aged ; Aged, 80 and over ; Biomarkers, Tumor/genetics ; Breast Neoplasms/genetics ; Breast Neoplasms/pathology ; Chemotherapy, Adjuvant/adverse effects ; Disease-Free Survival ; Female ; Gene Expression Regulation, Neoplastic/drug effects ; Humans ; Lymph Nodes/pathology ; Middle Aged ; Neoplasm Recurrence, Local/genetics ; Neoplasm Recurrence, Local/pathology ; Prognosis ; Risk Factors
Czasopismo naukowe
    Wyświetlanie 1-4 z 4

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies